Tergus Pharma
Where the Art+Science of topical
development meet
Our Competence
Topical Formulation Development
Tergus Pharma is a One-Stop Solution for all of Your Topical Formulation Development Needs.
Manufacturing Facility
Tergus has a state-of-the-art semi-solid manufacturing facility and extensive expertise in the management and...
IVRT (Franz Diffusion)
Tergus Pharma provides significant expertise in In vitro Release Rate Test (IVRT) Method Development & Validation.
Skin Biology
Your API needs to reach its target and maintain efficacy, so skin penetration and permeation studies are a necessity.
As a CRO (Contract Research Organization), Tergus provides topical pharmaceutical R&D, testing and manufacturing services to companies of all sizes with agile and custom solutions. The industry experts in our team apply QbD (Quality by Design) principles to help you with formulation development, analysis, testing and clinical supply manufacturing. We excel in providing you with the best solution and take immense care in risk mitigation strategies.
Read More- Service Spotlight
- Request for Proposal
- News/Events
- Follow us on Twitter/Linkedin
Latest News
- Dawn Slann joined Tergus effective June 11, 2018 in the capacity of Senior Director, Quality Assurance.
June 13, 2018) - Tergus Announces Key Leadership Changes
April 25, 2018)
Upcoming Events
Upcoming Events
Read MoreFacebook Posts
Aspirin is not just the first and common drug but also the most researched drugs in the world which has wide usage in the Pharma Industry.
#Aspirin #Dermatology #Pharmaceutical #TergusPharma
A new innovation in the field of dermatology by Skinonymize Team through which clinical photos can be de-identified by computer vision.
#Dermatology #Pharmaceutical #PharmaIndustry #TergusPharma
With the alliance with many CROs in IND-exploratory toxicology studies, we provide guidance and consultancy services for topical administration and development and repurposing a known molecule.
#Pharmaceutical #Dermatology #TergusPharma
Come along and perceive the insights of the Pharmaceutical Industry at CPhI North America, 2019 on 30th April to 3rd May in Chicago.
Please visit our table or stop by Booth #2142 to discuss your future on topical/dermatological opportunities.
#1daytogo #CPhINorthAmerica #Dermatology #Pharmaceutical #PharmaIndustry #TergusPharma
The AAD recommends moisturizing daily and avoiding products that contain excipients like urea, alcohol, and glycolic and lactic acids. Develop your products wisely in treating the Rosacea.
#RosaceaMonth #Redness #Dermatitis #TergusPharma